Tag: research

James was first diagnosed with a brain tumour after having a seizure in 2018. Since then, he has had two awake craniotomies and a string of treatment types. Here, he shares his story on how he has navigated the uncertainty which came with it all.

The second part of our interview with Sigourney Bell, a third-year PHD candidate at the CRUK Cambridge Institute and co-Founder of Black in Cancer.

We spoke with Sigourney Bell, a third-year PHD candidate at the CRUK Cambridge Institute and co-Founder of Black in Cancer, about her experiences as a researcher.

Verbal fluency test to name animals found to identify those with persistent headaches who are more likely to have a brain tumour, and could help GPs decide who needs rapid imaging.

In this blog, Stephen tells us why it is so important to take part in clinical research. He talks us through his experience of volunteering in the Sativex clinical trial (Phase 1) and joining the Involvement Network.

We respond to preliminary overall survival data from phase III clinical trial that suggests DCVax-L may help extend survival for patients with newly-diagnosed or recurrent glioblastomas.

New Year, new research grant opportunities as The Charity is returning to traditional research funding after the pandemic pause with our substantial Future Leaders grants.

A major UK trial of cannabis-based drug Sativex in treating the most aggressive form of brain tumour is to launch at 15 NHS hospitals, following promising results from a phase I study in 27 patients.

Geneticists from Trinity College Dublin have discovered how a specific genetic mutation called H3K27M causes a devastating, incurable childhood cancer, known as diffuse midline glioma (DMG), and, in lab studies working with model cell types, successfully reverse its effects to slow cancer cell growth with a targeted drug.

If we can find a way to interrupt a cancer cell’s ability to keep dividing, we may have a key to stopping tumours growing. Researchers, Dr Wong and Dr Voon ,tells us about the discovery they made into a tumour’s ability to continuously divide.

Research we funded has added value to a clinical trial that started in 2004. Updated scientific techniques showed that some children with a medulloblastoma can safely be spared harmful treatments.

Artificial intelligence (AI) may be the key to fast and consistent renal cell tumour diagnoses, all because of work we fund on brain tumours.

Back in 2015 we launched our five year strategy ‘Defeating Brain Tumours’ and our research strategy ‘A Cure Can’t Wait’. Our manifestos were unashamedly ambitious, but we knew they had to be.

A new publication from one of our research projects shines a light on the differences between the cells in the middle/core of a glioblastoma (GBM) compared to the cells spreading/infiltrating into healthy brain around the tumour.

Dr Gelareh Zadeh is leading research in Canada which will help predict the risk of meningioma regrowth.

In April, NHSX, the unit whose remit is to deliver the digital transformation of the health service, will begin running a new artificial intelligence (AI) Lab.

Brain tumours among diseases that miss out on research funding, says our joint charity report

For a limited time the voting is open to decide the semifinalists in our Brain Race, with the Centre for Advancing Innovation. Which discoveries do you want to see go forward?

Dr Martina Finetti tells us about her background and her research into rare childhood brain tumours.

Our Research Communications & Engagement Officer, Arshiya, shares some of the most exciting highlight from the 2019 annual British Neuro-Oncology Society (BNOS) conference.

We’re delighted to announce our £1.35m investment in a pioneering drive to help accelerate research into brain tumours at one of the UK’s leading universities.

Our Research Communications & Engagement Officer, Arshiya, shares some of the most exciting results from the American Society of Clinical Oncology (ASCO) conference

Our funded research has created a tool to help clinicians predict meningioma recurrence

Scottish scientist set to receive over £6 million from Cancer Research UK and The Brain Tumour Charity to find new ways to treat glioblastoma, one of the hardest types of cancer to treat.